title: [Cabergoline].
authors.affiliation: I. Medizinische Klinik, Christian-Albrechts-Universität, Kiel.
authors.forename: H
authors.initials: H
authors.lastname: Mönig
authors.forename: P
authors.initials: P
authors.lastname: Krack
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D004873:Ergolines / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D005260:Female; D006801:Humans; D011247:Pregnancy; D011388:Prolactin / Q000037:antagonists & inhibitors
chemical_list: D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D004873:Ergolines; D011388:Prolactin; D000077465:Cabergoline
vernacular_title: Cabergolin.